TCDD exposure is well known to reorganize AhR target gene expression as well as other pro-inflammatory pathways in the liver to promote glucose intolerance and other related metabolic disturbances [15,39,40,41,42,43]. The gene discussed is AHR; the disease is Glucose intolerance.